{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:05:36Z","timestamp":1788505536719,"version":"build-2803163510"},"reference-count":16,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The European Journal of Contraception & Reproductive Health Care"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1080\/13625180008500383","type":"journal-article","created":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T04:32:06Z","timestamp":1149827526000},"page":"105-112","source":"Crossref","is-referenced-by-count":31,"title":["Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?"],"prefix":"10.1080","volume":"5","author":[{"given":"M.","family":"Spannagl","sequence":"first","affiliation":[{"name":"Ludwig-Maximilian University, Department of Hemostasiology, City Center Clinic, Medical Hospital, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A. J.","family":"Heinemann","sequence":"additional","affiliation":[{"name":"Center for Epidemiology and Health Research, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Schramm","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilian University, Department of Hemostasiology, City Center Clinic, Medical Hospital, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,6]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90286-0"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91929-5"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1023875"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996034"},{"key":"e_1_2_1_6_1","first-page":"491","article-title":"Oral contraceptives and venous thromboembolism: acquired APC resistance?","volume":"98","author":"Schramm W","year":"1997","unstructured":"Schramm W, Heinemann L AJ. Oral contraceptives and venous thromboembolism: acquired APC resistance?. Br J Haematol 1997; 98: 491\u20132","journal-title":"Br J Haematol"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/369064a0"},{"key":"e_1_2_1_8_1","volume-title":"Statistical Software Package, Version 4.0","author":"STATA","unstructured":"STATA. Statistical Software Package, Version 4.0. Stata Press, East Station, Texas"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","DOI":"10.1080\/13625180008500392","article-title":"Venous thromboembolism and oral contraceptive use: a methodological study of diagnostic suspicion and referral bias","author":"Heinemann L AJ","year":"2000","unstructured":"Heinemann L AJ, Garbe E, Farmer R. Venous thromboembolism and oral contraceptive use: a methodological study of diagnostic suspicion and referral bias. Eur J Contracept Reprod Health Care 2000, submitted","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.8.2325"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/13625187.11661694.1996"},{"key":"e_1_2_1_12_1","first-page":"91","volume-title":"Fertility Control. Update and Trends","author":"Heinemann L AJ","year":"1998","unstructured":"Heinemann L AJ, Garbe E. Cardiovascular risks of oral hormonal contraception. Fertility Control. Update and Trends, T Rabe. Springer Publishers, New York, Heidelberg 1998; 91\u2013119"},{"key":"e_1_2_1_13_1","first-page":"148","volume-title":"Safety Requirements for Contraceptive Steroids","author":"Vessey M P","year":"1989","unstructured":"Vessey M P. Lessons learnt from epidemiology. Safety Requirements for Contraceptive Steroids, Michal. Cambridge University Press, Cambridge, New York 1989; 148\u201356"},{"key":"e_1_2_1_14_1","first-page":"531","article-title":"The occurrence of lung cancer in man","volume":"9","author":"Levin M L","year":"1953","unstructured":"Levin M L. The occurrence of lung cancer in man. Acta Union Int Cancer 1953; 9: 531\u201341","journal-title":"Acta Union Int Cancer"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07496-X"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of thromboembolic disease","volume":"133","author":"Gerstmann B B","year":"1991","unstructured":"Gerstmann B B, Piper J M, Tomita D K, et al. Oral contraceptive estrogen dose and the risk of thromboembolic disease. Am J Epidemiol 1991; 133: 32\u20137","journal-title":"Am J Epidemiol"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6519.526"}],"container-title":["The European Journal of Contraception & Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13625180008500383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T14:30:02Z","timestamp":1727965802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13625180008500383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1080\/13625180008500383"],"URL":"https:\/\/doi.org\/10.1080\/13625180008500383","relation":{},"ISSN":["1362-5187","1473-0782"],"issn-type":[{"value":"1362-5187","type":"print"},{"value":"1473-0782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}